Increased serum uric acid levels are correlated with decreased left atrial appendage peak flow velocity in patients with atrial fibrillation

Medical Principles and Practice

Volumn 24, Issue 3, 2015, Pages 263-268

  Celik, Murat ^a   Yalcinkaya, Emre ^b   Yuksel, Uygar Cagdas ^a   Gokoglan, Yalcin ^a   Bugan, Baris ^c   Kabul, Hasan Kutsi ^a   Barcin, Cem ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Department of Cardiology   (Turkey)

^c Girne Military Hospital   (Cyprus)

Author keywords

Atrial fibrillation; Left atrial appendage peak flow velocity; Serum uric acid level

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UREA; URIC ACID;

AGE DISTRIBUTION; AGED; ARTICLE; ATRIAL FIBRILLATION; BLOOD FLOW VELOCITY; CARDIOVERSION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM APPENDAGE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SEX DIFFERENCE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; URIC ACID BLOOD LEVEL; AGE; BLOOD; COMORBIDITY; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

AGE FACTORS; AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; BLOOD FLOW VELOCITY; COMORBIDITY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX FACTORS; URIC ACID;

EID: 84929953746     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000373892     Document Type: Article

References (25)

1. Ruggiero C, Cherubini A, Ble A, et al: Uric acid and inflammatory markers. Eur Heart J 2006; 27: 1174-1181.
2. Hoeper MM, Hohlfeld JM, Fabel H: Hyperuricaemia in patients with right or left heart failure. Eur Respir J 1999; 13: 682-685.
3. Culleton BF, Larson MG, Kannel WB, et al: Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999; 131: 7-13.
4. Korantzopoulos P, Letsas KP, Liu T: Xanthine oxidase and uric acid in atrial fibrillation. Front Physiol 2012; 3: 150.
5. Letsas KP, Korantzopoulos P, Filippatos GS, et al: Uric acid elevation in atrial fibrillation. Hellenic J Cardiol 2010; 51: 209-213.
6. Tamariz L, Agarwal S, Soliman EZ, et al: Association of serum uric acid with incident atrial fibrillation [from the Atherosclerosis Risk in Communities (ARIC) study]. Am J Cardiol 2011; 108: 1272-1276.
7. Hoit BD, Shao Y, Tsai LM, et al: Altered left atrial compliance after atrial appendectomy. Influence on left atrial and ventricular filling. Circ Res 1993; 72: 167-175.
8. Bo S, Gambino R, Durazzo M, et al: Associations between serum uric acid and adipokines, markers of inflammation, and endothelial dysfunction. J Endocrinol Invest 2008; 31: 499-504.
9. Ames BN, Cathcart R, Schwiers E, et al: Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981; 78: 6858-6862.
10. Hoieggen A, Alderman MH, Kjeldsen SE, et al: The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004; 65: 1041-1049.
11. Kaya MG, Uyarel H, Akpek M, et al: Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2012; 109: 486-491.
12. Johnson RJ, Kang DH, Feig D, et al: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease Hypertension 2003; 41: 1183-1190.
13. Taheraghdam AA, Sharifipour E, Pashapour A, et al: Allopurinol as a preventive contrivance after acute ischemic stroke in patients with a high level of serum uric acid: a randomized, controlled trial. Med Princ Pract 2014; 23: 134-139.
14. Krishnan E, Pandya BJ, Chung L, et al: Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol 2012; 176: 108-116.
15. Al-Meshaweh AF, Jafar Y, Asem M, et al: Determinants of blood uric acid levels in a dyslipidemic Arab population. Med Princ Pract 2012; 21: 209-216.
16. Horio T, Iwashima Y, Kamide K, et al: Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients. J Hypertens 2010; 28: 1738-1744.
17. Ito H, Abe M, Mifune M, et al: Hyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus. PLoS One 2011; 6:e27817.
18. Nattel S: Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management Cardiovasc Res 2002; 54: 347-360.
19. Suzuki S, Sagara K, Otsuka T, et al: Genderspecific relationship between serum uric acid level and atrial fibrillation prevalence. Circ J 2012; 76: 607-611.
20. Kuwabara M, Niwa K, Niinuma H: Hyperuricemia is an independent risk factor of atrial fibrillation due to electrical remodeling through activation of uric acid transporter (abstract). ACC 2012. J Am Coll Cardiol 2012; 59(suppl A):A163.
21. Korantzopoulos P, Kolettis TM, Galaris D, et al: The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007; 115: 135-143.
22. Mihm MJ, Yu F, Carnes CA, et al: Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001; 104: 174-180.
23. Van Wagoner DR: Molecular basis of atrial fibrillation: a dream or a reality J Cardiovasc Electrophysiol 2003; 14: 667-669.
24. Dudley SC Jr, Hoch NE, McCann LA, et al: Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 2005; 112: 1266-1273.
25. Michelena HI, Powell BD, Brady PA, et al: Gender in atrial fibrillation: ten years later. Gend Med 2010; 7: 206-217.